Skip to main content

Table 2 Comparison between the studied groups regarding LHRmRNA tissue expression

From: Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways

RQ of LHRmRNA

Group

H P

Control

Benign

Borderline

Malignant

• Mean

0.065

1.426

19.998

25.047

0.001*

• SD

0.073

0.900

31.066

53.626

  1. RQ relative quantification, H Kruskal-Wallis test, *P < 0.05 (significant)
Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us